Your browser doesn't support javascript.
loading
Population PKPD modeling of BACE1 inhibitor-induced reduction in Aß levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pig.
Janson, Juliette; Eketjäll, Susanna; Tunblad, Karin; Jeppsson, Fredrik; Von Berg, Stefan; Niva, Camilla; Radesäter, Ann-Cathrin; Fälting, Johanna; Visser, Sandra A G.
Affiliation
  • Janson J; Modeling & Simulation, DMPK, Innovative Medicines CNSP AstraZeneca, SE-15185, Södertälje, Sweden, juliettejanson@yahoo.com.
Pharm Res ; 31(3): 670-83, 2014 Mar.
Article in En | MEDLINE | ID: mdl-24092053

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Amyloid beta-Peptides / Aspartic Acid Endopeptidases / Enzyme Inhibitors / Amyloid Precursor Protein Secretases / Alzheimer Disease / Neurons Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Pharm Res Year: 2014 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Amyloid beta-Peptides / Aspartic Acid Endopeptidases / Enzyme Inhibitors / Amyloid Precursor Protein Secretases / Alzheimer Disease / Neurons Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Pharm Res Year: 2014 Document type: Article